Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children.

Pneumococcal DNA is not detectable in the blood of healthy carrier children by real-time PCR targeting the lytA gene.